🔎 Trials Near Me

Beranda › Miastenia Gravis › Kansas

Uji klinis Miastenia Gravis di Kansas

7 studi untuk Miastenia Gravis mencari peserta di lokasi di Kansas.

Kota di Kansas

Teks studi resmi (Bahasa Inggris)

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  • University of Kansas Medical Center Research Institute, Inc. - 3901 Rainbow (MAIN), Kansas City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06463587

Zilucoplan for Severe gMG Exacerbations

  • University of Kansas Medical Center, Kansas City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07215949

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

  • University of Kansas Medical Center, Kansas City
Menerima pesertaFase 1/2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT06359041

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  • University of Kansas Medical Center, Kansas City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT04951622

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

  • University of Kansas Medical Center, Kansas City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Jun 2026 · NCT06456580

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

  • University of Kansas Medical Center, Kansas City
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT06298565

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis

  • University of Kansas Clinical Research Center, Fairway
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Apr 2025 · NCT06064695

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.